NASDAQ · Analyst Forecast

Korro Bio, Inc. (KRRO) Stock Forecast & Price Target

$12.32 NASDAQ: KRRO Market Cap $169.10M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Korro Bio, Inc. (KRRO), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Korro Bio, Inc., analysts forecast revenue rising from $5.52M in 2025 to $23.98M in 2030; the average estimate for 2030 earnings per share is −$4.95; with published estimates ranging from −$4.96 to −$4.94; 8 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$12.32
Consensus targetThe average of the price targets analysts have published.$15.00
Median targetThe middle target, less affected by a single outlier.$15.00
Highest targetThe most optimistic published target.$15.00
Lowest targetThe most pessimistic published target.$15.00
Difference from priceHow far the consensus target sits from today’s price.+21.8%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$5.18M$5.52M$6.71M7
2026$1.73M$1.74M$1.74M8
2027$299,565$300,000$300,4348
2028$1.35M$1.35M$1.35M7
2029$16.14M$16.16M$16.19M2
2030$23.95M$23.98M$24.02M4

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$9.53−$9.03−$8.457
2026−$5.13−$4.88−$4.678
2027−$5.52−$4.80−$3.698
2028−$5.02−$4.03−$2.867
2029−$4.71−$4.70−$4.692
2030−$4.96−$4.95−$4.944

Korro Bio, Inc. (KRRO) forecast — frequently asked questions

What is the analyst price target for Korro Bio, Inc.?

Analysts covering Korro Bio, Inc. (KRRO) have a consensus price target of $15.00, 21.8% above the current price of $12.32. Published targets range from $15.00 to $15.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Korro Bio, Inc.'s earnings?

The average analyst estimate for Korro Bio, Inc. (KRRO) earnings per share in 2030 is -4.95, with individual estimates between -4.96 and -4.94.

How much revenue is Korro Bio, Inc. expected to make?

Analysts forecast Korro Bio, Inc. (KRRO) revenue of $23.98M in 2030, based on 4 published estimates.

How many analysts cover KRRO?

8 analysts contribute estimates for Korro Bio, Inc. (KRRO). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.